Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cathepsin B expression in human tumors

I M Berquin1, B F Sloane

  • 1Wayne State University, Department of Pharmacology, Detroit, Michigan 48201, USA.

Advances in Experimental Medicine and Biology
|January 1, 1996
PubMed
Summary

Cathepsin B activity is elevated in malignant tumors and may drive cancer progression. Understanding its complex gene regulation offers new therapeutic strategies to reduce tumor activity.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cell type-dependent pathogenic functions of overexpressed human cathepsin B in murine breast cancer progression.

Oncogene·2013
Same author

MKNK1 is a YB-1 target gene responsible for imparting trastuzumab resistance and can be blocked by RSK inhibition.

Oncogene·2012
Same author

YB-1 evokes susceptibility to cancer through cytokinesis failure, mitotic dysfunction and HER2 amplification.

Oncogene·2011
Same author

The transcriptional induction of PIK3CA in tumor cells is dependent on the oncoprotein Y-box binding protein-1.

Oncogene·2009
Same author

Cathepsin K in the bone microenvironment: link between obesity and prostate cancer?

Biochemical Society transactions·2007
Same author

Peptidylprolyl isomerase A (PPIA) as a preferred internal control over GAPDH and beta-actin in quantitative RNA analyses.

BioTechniques·2002

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • Cathepsin B activity, secretion, and membrane association increase with tumor malignancy.
  • Elevated Cathepsin B is observed at the invasive edges of tumors.
  • Cathepsin B may directly degrade extracellular matrix or indirectly activate other proteases, facilitating tumor invasion, growth, and angiogenesis.

Purpose of the Study:

  • To investigate the regulatory mechanisms controlling Cathepsin B expression and activity in tumors.
  • To explore the potential for novel therapeutic strategies targeting Cathepsin B.

Main Methods:

  • Analysis of Cathepsin B mRNA, protein levels, and activity in tumor samples.
  • Investigation of transcriptional and post-transcriptional regulation, including promoter usage and alternative splicing.
  • Examination of transcript variants and their potential impact on protein function.

Main Results:

  • Cathepsin B expression and activity correlate with tumor progression in some cancers like gliomas.
  • Evidence suggests multiple promoters and alternative splicing contribute to Cathepsin B transcript diversity.
  • Transcript variants may lead to altered mRNA stability, translatability, and potentially truncated proteins with unclear functions.
  • Ras-transformation increased Cathepsin B protein without a corresponding mRNA increase, indicating post-transcriptional regulation.

Conclusions:

  • Cathepsin B plays a significant role in tumor progression and invasion.
  • Regulation of Cathepsin B involves complex transcriptional and post-transcriptional mechanisms.
  • Understanding these regulatory pathways is crucial for developing targeted therapies to inhibit Cathepsin B activity in cancer.

Related Experiment Videos